The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine
PFS was significantly prolonged: as assessed by BICR, the risk of disease…
October 25, 2026
Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026
HONG KONG and SHANGHAI, Oct. 25, 2026 /PRNewswire/ — The Seminar on…
October 25, 2026
2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer
SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PRNewswire/ — Innovent Biologics,…
October 25, 2026
2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC
SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PRNewswire/ — Innovent Biologics, Inc.…
October 25, 2026
ST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East
Intuition ground system selected to support MBSat’s planned 2027 service launch, enabling…
October 25, 2026
Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting
SHAOXING, China, Oct. 25, 2026 /PRNewswire/ — At the 2026 ESMO Annual Meeting,…
October 25, 2026
World Young Scientist Summit 2026 Opens in Wenzhou, Zhejiang
WENZHOU, China, Oct. 24, 2026 /PRNewswire/ — This is a report by…
October 24, 2026
The Ultimate Send-off to Summer: CSTS Debuts Global Entertainment IP PremierX at New York's Pier 17, Ushering in a New Era of Live Entertainment
NEW YORK, Oct. 24, 2026 /PRNewswire/ — CSTS Enterprises (‘CSTS’), a New…
